Related Experiment Video
Updated: Aug 5, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Continuous Intra-arterial Nimodipine Therapy in SAH Patients With Refractory DCI-Factors Associated With Insufficient
Elena Kurz1, Darius Kalasauskas1, Florian Ringel1
1Department of Neurosurgery, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Insights
Continuous intra-arterial nimodipine infusion (CIAN) is a feasible rescue therapy for delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH). However, recurrence was common, and insufficient response correlated with severe disease markers and poor outcomes.
Area of Science:
- Neuroendovascular therapy
- Cerebrovascular diseases
- Neurosurgery
Background:
- Continuous intra-arterial nimodipine infusion (CIAN) serves as an endovascular rescue therapy for refractory delayed cerebral ischemia (DCI) following aneurysmal subarachnoid hemorrhage (aSAH).
- The efficacy, response rates, and recurrence patterns of CIAN remain incompletely understood.
Purpose of the Study:
- To evaluate the effectiveness and outcomes of CIAN in patients with refractory DCI after aSAH.
- To characterize treatment response, vasospasm recurrence, and associated clinical factors.
Main Methods:
- A retrospective analysis of 36 aSAH patients treated with CIAN between 2016 and 2023.
- Patients had imaging-confirmed vasospasm and perfusion deficits refractory to standard treatments.
- Key outcomes included treatment response, recurrence, DCI-related infarctions, and 6-month functional outcome (mRS).
Main Results:
- 44% of patients achieved a sufficient response (>75% vessel caliber restoration with perfusion improvement).
- Recurrence occurred in 39% of patients, with 19% requiring repeat CIAN.
- Insufficient response was linked to higher WFNS/mFS scores, multiple aneurysms, generalized vasospasm, and unfavorable outcomes.
Conclusions:
- CIAN is a feasible endovascular rescue strategy for selected aSAH patients with refractory DCI.
- Vasospasm recurrence is common, and insufficient response is associated with severe disease indicators.
- Further prospective studies are warranted to optimize CIAN protocols and patient selection.
Background:
Continuous intra-arterial nimodipine infusion (CIAN) is an endovascular rescue therapy for refractory delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH). Response and recurrence remain incompletely characterized.
Methods:
We retrospectively analyzed aSAH patients treated with CIAN (2016-2023) for imaging-confirmed vasospasm with perfusion deficits refractory to induced hypertension and intermittent intra-arterial nimodipine; microcatheters were placed in internal carotid or vertebral arteries. Analyzed variables included clinical characteristics, aneurysm parameters, WFNS, modified Fisher score (mFS), treatment response, vasospasm recurrence, DCI-associated infarctions, CSF diversion, and 6-month modified Rankin Scale (mRS). Sufficient response was defined as >75% restoration of baseline vessel caliber with perfusion improvement.
Results:
Of 36 patients (mean age 53 ± 12 years; 75% female), 16 (44%) responded sufficiently and 20 (56%) insufficiently. Recurrence after discontinuation occurred in 14 (39%); 7 (19%) required repeat CIAN. Insufficient response was associated with higher WFNS and mFS, multiple aneurysms, and generalized vasospasm. Insufficient response co-occurred with more DCI-related infarctions and unfavorable outcome but, given the overlap with baseline severity markers, likely reflects severe underlying vasospasm biology rather than an independent therapeutic effect. Procedure-related complications were uncommon and not associated with infarction or outcome deterioration.
Conclusions:
CIAN is a feasible endovascular rescue strategy in selected patients with refractory DCI, although recurrence was common. Insufficient response clustered with markers of severe disease-higher WFNS and mFS, younger age, multiple aneurysms, generalized vasospasm-and was associated with unfavorable outcome. This study generates hypotheses for prospective studies.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Angina II: Classification
Acute Coronary Syndrome V: Nursing Management